ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997

UCSD Cancer Center Breaks Ground for New Building

November 15, 2002

Cancer Caused By Environmental Exposure “Grossly Underestimated,” Cancer Panel Says.

May 7, 2010

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010

SWOG Wins NCI Grant Renewal For Six Years

April 16, 2010